z-logo
Premium
Streptococcus agalactiae Infection in Domestic Rabbits, Oryctolagus cuniculus
Author(s) -
Ren S. Y.,
Geng Y.,
Wang K. Y.,
Zhou Z. Y.,
Liu X. X.,
He M.,
Peng X.,
Wu C. Y.,
Lai W. M.
Publication year - 2014
Publication title -
transboundary and emerging diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.392
H-Index - 63
eISSN - 1865-1682
pISSN - 1865-1674
DOI - 10.1111/tbed.12073
Subject(s) - streptococcus agalactiae , biology , microbiology and biotechnology , ampicillin , amoxicillin , gentamicin , group b , penicillin , respiratory distress , tetracycline , antibiotics , streptococcus , bacteria , medicine , genetics , anesthesia
Streptococcus agalactia e (Group B streptococcus, GBS ) has emerged as an important pathogen that affects humans and animals, including aquatic species. In August 2011, a severe infectious disease affecting rabbits, which caused 42% mortality, occurred in M ianyang, S ichuan Province, C hina. The main clinical signs included acute respiratory distress syndrome, fever, paddling and convulsions. A Gram‐positive, chain‐forming coccus was isolated from the primary organs and tissues of diseased rabbits and then identified as S . agalactiae by morphology, biochemical and physiological characteristics, 16 S r DNA and gyr B gene sequences analysis. All isolates of S . agalactiae showed a similar antibiotic susceptibility, which were sensitive to florfenicol, ampicillin,gentamicin and norfloxacin, as well as being resistant to penicillin, amoxicillin and tetracycline. To our knowledge, this is the first report on S . agalactiae natural infection in domestic rabbits.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom